Atlas Trials

Sugammadex and Neostigmine at Residual Neuromuscular Blockade

Clinical trial NCT01006720 · COMPLETED

Trial details

NCT number
NCT01006720
Sponsor
Technical University of Munich
Status
COMPLETED
Study type
OBSERVATIONAL
Residual Neuromuscular Block (TOF-ratio of 0.2)
Start date
2009-03-01
Primary completion
2009-07-01
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.